QCG
MJN

Quadrant Capital Group’s Mead Johnson Nutrition Company MJN Stock Holding History

Quadrant Capital Group’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-522
Closed -$43K – 2212
2017
Q1 		$43K Buy
522
+100
+24% +$8.22K 0.02% 612
2016
Q4 		$27K Sell
422
-718
-63% -$53.5K 0.01% 656
2016
Q3 		$87K Buy
1,140
+583
+105% +$49.7K 0.06% 281
2016
Q2 		$45K Sell
557
-577
-51% -$48.9K 0.03% 429
2016
Q1 		$94K Buy
1,134
+127
+13% +$9.45K 0.06% 235
2015
Q4 		$76K Buy
1,007
+67
+7% +$5.28K 0.05% 290
2015
Q3 		$65K Buy
940
+608
+183% +$50K 0.04% 336
2015
Q2 		$29K Buy
+332
New +$32K 0.02% 549

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Quadrant Capital Group's MJN Position: Q2 2017 in Review

Quadrant Capital Group sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 522 shares — an estimated $43K sold.

Quadrant Capital Group first reported a position in MJN in Q2 2015 and held it in 8 quarters. The position peaked at $94K in Q1 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Quadrant Capital Group reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Quadrant Capital Group sold 522 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $43K.
  • Quadrant Capital Group first reported a position in Mead Johnson Nutrition Company in Q2 2015 and held it in 8 quarters.
  • Quadrant Capital Group's Mead Johnson Nutrition Company position peaked at $94K in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Quadrant Capital Group's 13F filing for Q2 2017, filed 15 Aug 2017.